ATEC vs. MASI, GMED, TFX, ITGR, ATRC, IART, OFIX, SRDX, ANGO, and ARAY
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Masimo (MASI), Globus Medical (GMED), Teleflex (TFX), Integer (ITGR), AtriCure (ATRC), Integra LifeSciences (IART), Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), and Accuray (ARAY). These companies are all part of the "health care equipment" industry.
Alphatec vs. Its Competitors
Alphatec (NASDAQ:ATEC) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.
Alphatec has a net margin of -24.33% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat Alphatec's return on equity.
Alphatec has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Masimo has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500.
Alphatec presently has a consensus price target of $18.50, suggesting a potential upside of 21.55%. Masimo has a consensus price target of $194.60, suggesting a potential upside of 36.08%. Given Masimo's higher probable upside, analysts clearly believe Masimo is more favorable than Alphatec.
In the previous week, Masimo had 10 more articles in the media than Alphatec. MarketBeat recorded 13 mentions for Masimo and 3 mentions for Alphatec. Alphatec's average media sentiment score of 1.81 beat Masimo's score of 0.82 indicating that Alphatec is being referred to more favorably in the media.
66.4% of Alphatec shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 20.9% of Alphatec shares are held by insiders. Comparatively, 9.7% of Masimo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Alphatec has higher earnings, but lower revenue than Masimo. Masimo is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.
Summary
Masimo beats Alphatec on 9 of the 16 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
This page (NASDAQ:ATEC) was last updated on 9/19/2025 by MarketBeat.com Staff
Free ATEC Stock Alerts